Comparing Arcalyst vs Kineret
Arcalyst (rilonacept) | Kineret (anakinra) |
|
---|
Arcalyst (rilonacept) | Kineret (anakinra) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Pericarditis, Familial Cold Autoinflammatory Syndrome, Cryopyrin-Associated Periodic Syndromes, Muckle Wells Syndrome, Interleukin-1 Receptor Antagonist Deficiency. Arcalyst may also... View more |
Prescription only
Prescribed for Cryopyrin-Associated Periodic Syndromes, Rheumatoid Arthritis, COVID-19, Interleukin-1 Receptor Antagonist Deficiency. Kineret may also be used for purposes not listed in this medication guide. View more |
Related suggestions Cryopyrin-Associated Periodic Syndromes
Interleukin-1 Receptor Antagonist Deficiency
|
|||||||||||||||
More about Arcalyst (rilonacept) | More about Kineret (anakinra) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Arcalyst has an average rating of 10.0 out of 10 from a total of 6 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Kineret has an average rating of 9.0 out of 10 from a total of 10 ratings on Drugs.com. 90% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Arcalyst side effects |
View all Kineret side effects |
||||||||||||||||
Drug Class | |||||||||||||||||
Generic Availability | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Arcalyst prices |
View all Kineret prices |
||||||||||||||||
Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
N/A |
6 hours |
||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 518 drugs are known to interact with Arcalyst:
|
A total of 519 drugs are known to interact with Kineret:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
February 27, 2008 |
November 14, 2001 |
||||||||||||||||
WADA Class View classifications | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient Resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Actemra
Actemra is used to treat COVID-19, rheumatoid arthritis, systemic juvenile idiopathic arthritis ...
Adbry
Adbry is used to treat moderate-to-severe atopic dermatitis (eczema) in adults and children aged 12 ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Bimzelx
Bimzelx (bimekizumab) treats plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and ...
Cinqair
Cinqair (reslizumab) is a monoclonal antibody that affects the actions of the body's immune system ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Ebglyss
Ebglyss (lebrikizumab) is a treatment for moderate-to-severe atopic dermatitis given as a monthly ...
Enspryng
Enspryng is used to treat neuromyelitis optica spectrum disorder (NMOSD) in adults who are ...
Fasenra
Fasenra injection is used to treat severe eosinophilic asthma in adults and children aged 6 and ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.